Oncology APISintaho Pharmaceutical Ltd was established in the year of 2016 and headquartered in Chongqing China, with a grand vison of being the most trusted partner to pharmaceutical companies worldwide. We have a clear focus on developing and manufacturing highly potent and cytotoxic Active Pharmaceutical Ingredients (APIs) and CDMO services.
*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Semi-synthetic Paclitaxel is a chemically derived antineoplastic agent produced from 10-deacetylbaccatin III extracted from <strong>Taxus</strong> species. It stabilizes microtubules to inhibit cell division. Molecular formula: C<sub>47</sub>H<sub>51</sub>NO<sub>14</sub>; CAS No.: 33069-62-4.</p>
<h3>Application</h3>
<ul>
<li>Oncology: Treatment of ovarian, breast, and non-small cell lung cancers.</li>
<li>Manufacturing: API production for injectable formulations and generic drugs.</li>
<li>Research: Tool compound for studying cell cycle regulation mechanisms.</li>
</ul>
<h3>Precautions</h3>
<p>Requires strict handling due to cytotoxicity. Store in cool, dry conditions below 25°C away from light. Use appropriate PPE to prevent skin contact and inhalation during processing.</p>